Core Viewpoint - InMode (INMD) reported quarterly earnings of $0.70 per share, exceeding the Zacks Consensus Estimate of $0.57 per share, and showing an increase from $0.61 per share a year ago, representing an earnings surprise of 22.81% [1][2] Financial Performance - The company achieved revenues of $130.23 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 0.18% and up from $123.11 million year-over-year [2] - Over the last four quarters, InMode has consistently surpassed consensus EPS estimates and revenue estimates [2] Stock Performance - InMode shares have declined approximately 19.5% since the beginning of the year, contrasting with the S&P 500's gain of 22.3% [3] - The current Zacks Rank for InMode is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $0.56 on revenues of $112.3 million, while the estimate for the current fiscal year is $1.78 on revenues of $409.1 million [7] - The trend of estimate revisions for InMode is currently mixed, which may change following the recent earnings report [6] Industry Context - The Medical - Products industry, to which InMode belongs, is currently ranked in the top 25% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]
InMode (INMD) Q3 Earnings and Revenues Beat Estimates